Adipic Acid

Adipic Acid

SCHEMBL166309

CN1CCc2ccccc2CC1.O=C(O)CCCCC(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC18A2SLC6A2SLC6A3

The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 known ✓ Q01959 1/20 0.47
DRD2 P14416 8/20 0.60
DRD1 P21728 7/20 0.60
DRD5 P21918 7/20 0.60
DRD3 P35462 7/20 0.60
DRD4 P21917 5/20 0.60
KDM4E B2RXH2 1/20 0.57
MEN1 O00255 1/20 0.57
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
KMT2A Q03164 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MAOA P21397 2/20 0.55
MAOB P27338 2/20 0.55
NOTUM Q6P988 1/20 0.51
HTR1A P08908 1/20 0.50
HTR2A P28223 1/20 0.50
SLC6A4 P31645 1/20 0.50
HTR7 P34969 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL170445 0.93 DRD2 (0.64) DRD2DRD1DRD5DRD3DRD4
SCHEMBL17598257 0.82 HDAC3 (0.71) DRD2DRD3KDM4EHTR1AHTR2A
Adipic Acid SCHEMBL161400 0.81 HTR7 (0.50) DRD2DRD3KDM4EMEN1POLB
Adipic Acid SCHEMBL160638 0.81 KDM4E (0.46) DRD2DRD1DRD5DRD3DRD4
SCHEMBL8687907 0.80 HTR7 (0.76) DRD2DRD3KDM4EHTR1AHTR2A
Hydrochloric Acid SCHEMBL3887340 0.79 HTR7 (0.74) DRD2DRD3KDM4EHTR1AHTR2A
SCHEMBL164206 0.78 DRD1 (0.85) DRD2DRD1DRD5DRD3DRD4
SCHEMBL29391320 0.78 DRD1 (0.85) DRD2DRD1DRD5DRD3DRD4
Fumaric Acid SCHEMBL12467794 0.78 DRD2 (0.59) DRD2DRD1DRD5DRD3DRD4
Maleic Acid SCHEMBL167958 0.78 DRD2 (0.59) DRD2DRD1DRD5DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed